Showing results (41-50 of 697) with videos related to
Sort By:
Pageof 70
IEEE Transactions on Bio-Medical Engineering|August 1, 2002
Forecasting the performance status of head and neck cancer patient treatment by an interval arithmetic pruned perceptronGian Paolo Drago, Ernesto Setti, Lisa Licitra, et al.European Journal of Cancer (Oxford, England : 1990)|September 24, 2025
The chemo-free approach for PDL1-positive platinum-sensitive recurrent/metastatic head and neck squamous cell carcinoma: Viable option or misguided myth?Stefano Cavalieri, Noemi Crippa, Benedetta Lombardi Stocchetti, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Immune escape associated with functional defects in antigen-processing machinery in head and neck cancerRobert L Ferris, Theresa L Whiteside, Soldano FerroneOral Oncology|October 16, 2013
Tailored immunotherapy for HPV positive head and neck squamous cell cancerNeil Gildener-Leapman, John Lee, Robert L FerrisMolecular Cancer Therapeutics|July 5, 2015
STAT1 Activation Is Enhanced by Cisplatin and Variably Affected by EGFR Inhibition in HNSCC CellsNicole C Schmitt, Sumita Trivedi, Robert L FerrisImmunologic Research|October 20, 2005
Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significanceRobert L Ferris, Jennifer L Hunt, Soldano FerroneHead & Neck|September 14, 2012
Use of molecular biomarkers in FNA specimens to personalize treatment for thyroid surgeryVikas Mehta, Yuri E Nikiforov, Robert L FerrisOral Oncology|November 5, 2019
Immunotherapy for head and neck cancer: Recent advances and future directionsJohn D Cramer, Barbara Burtness, Robert L FerrisCurrent Opinion in Otolaryngology & Head and Neck Surgery|March 11, 2016
Current understanding of the tumor microenvironment of laryngeal dysplasia and progression to invasive cancerSumita Trivedi, Clark A Rosen, Robert L FerrisStudies in Health Technology and Informatics|May 21, 2015
A mobile application supporting outpatient treatment and follow-upSerena Buzzacchino, Giordano Lanzola, Paolo Bossi, et al.Pageof 70